| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ANTHEM INC | 30,000 | 4,924,000 | 0.68% | ||
| 52 | JOHNSON & JOHNSON | 50,000 | 4,873,000 | 0.68% | ||
| 53 | EDWARDS LIFESCIENCES CORP | 34,100 | 4,857,000 | 0.67% | ||
| 54 | CLOVIS ONCOLOGY INC | 55,100 | 4,842,000 | 0.67% | ||
| 55 | AGIOS PHARMACEUTICALS INC | 41,000 | 4,557,000 | 0.63% | ||
| 56 | HUMANA INC | 23,500 | 4,495,000 | 0.62% | ||
| 57 | INSYS THERAPEUTICS INC NEW COM NEW | 120,000 | 4,310,000 | 0.60% | ||
| 58 | ACADIA PHARMACEUTICALS INC COM | 101,000 | 4,230,000 | 0.59% | ||
| 59 | ARIAD PHARMACEUTICALS ORD (NMS) | 495,000 | 4,094,000 | 0.57% | ||
| 60 | TELEFLEX INC | 30,000 | 4,064,000 | 0.56% | ||
| 61 | BRISTOL MYERS SQUIBB CO | 60,000 | 3,992,000 | 0.55% | ||
| 62 | MERCK & CO INC | 70,000 | 3,985,000 | 0.55% | ||
| 63 | CERNER CORP | 55,000 | 3,798,000 | 0.53% | ||
| 64 | Intersect ENT Inc | 130,000 | 3,722,000 | 0.52% | ||
| 65 | HCA HOLDINGS INC | 40,000 | 3,629,000 | 0.50% | ||
| 66 | VARIAN MED SYS INC | 42,000 | 3,542,000 | 0.49% | ||
| 67 | BLUEBIRD BIO INC COM | 20,000 | 3,367,000 | 0.47% | ||
| 68 | PFIZER INC | 100,000 | 3,353,000 | 0.47% | ||
| 69 | ACHILLION PHARMACEUTICALS IN | 376,000 | 3,331,000 | 0.46% | ||
| 70 | COOPER COS INC | 18,500 | 3,292,000 | 0.46% | ||
| 71 | NEUROCRINE BIOSCIE COM USD0.001 | 65,000 | 3,104,000 | 0.43% | ||
| 72 | HOLOGIC INC | 81,000 | 3,083,000 | 0.43% | ||
| 73 | MACROGENICS INC | 81,000 | 3,076,000 | 0.43% | ||
| 74 | Dentsply Intl Inc | 58,400 | 3,011,000 | 0.42% | ||
| 75 | MASIMO CORP | 75,000 | 2,906,000 | 0.40% | ||
| 76 | JUNO THERAPEUTICS INC COM | 48,000 | 2,560,000 | 0.36% | ||
| 77 | NEKTAR THERAPEUTICS COM | 200,000 | 2,502,000 | 0.35% | ||
| 78 | THORATEC LABS CORP | 55,000 | 2,451,000 | 0.34% | ||
| 79 | GLOBUS MED INC | 87,700 | 2,251,000 | 0.31% | ||
| 80 | Esperion Therapeutics Inc | 27,000 | 2,208,000 | 0.31% | ||
| 81 | HEALTHCARE SVCS GRP INC | 65,000 | 2,148,000 | 0.30% | ||
| 82 | NUVASIVE INC | 45,000 | 2,132,000 | 0.30% | ||
| 83 | HALOZYME THERAPEUTICS INC | 91,616 | 2,069,000 | 0.29% | ||
| 84 | DAVITA INC | 26,000 | 2,066,000 | 0.29% | ||
| 85 | STERICYCLE INC | 15,000 | 2,009,000 | 0.28% | ||
| 86 | SEATTLE GENETICS INC | 40,000 | 1,936,000 | 0.27% | ||
| 87 | CELLDEX THERAPEUTICS INC NEW | 74,000 | 1,866,000 | 0.26% | ||
| 88 | ABBVIE INC | 27,000 | 1,814,000 | 0.25% | ||
| 89 | INTERCEPT PHARMACEUTICALS INCORPORATED | 7,500 | 1,810,000 | 0.25% | ||
| 90 | INFINITY PHARMACEUTICALS INC | 164,000 | 1,796,000 | 0.25% | ||
| 91 | MANNKIND CORP. | 300,000 | 1,707,000 | 0.24% | ||
| 92 | WELLCARE HEALTH PLANS INC | 20,000 | 1,697,000 | 0.24% | ||
| 93 | THERMO FISHER SCIENTIFIC INC | 13,000 | 1,687,000 | 0.23% | ||
| 94 | LILLY ELI & CO | 20,000 | 1,670,000 | 0.23% | ||
| 95 | ANGIODYNAMICS INC | 100,000 | 1,640,000 | 0.23% | ||
| 96 | INOVIO PHARMACEUTICALS INC | 200,000 | 1,632,000 | 0.23% | ||
| 97 | INSULET CORPORATION | 52,500 | 1,627,000 | 0.23% | ||
| 98 | DANAHER CORP DEL | 19,000 | 1,626,000 | 0.23% | ||
| 99 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,618,000 | 0.22% | ||
| 100 | Heartware International, Inc. | 22,000 | 1,599,000 | 0.22% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008658, filed 2015.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
